**SpyGlass Pharma Completes IPO, Raising $172.5 Million**
SpyGlass Pharma, Inc., a late-stage biopharmaceutical company, has closed its initial public offering (IPO), selling a total of 10,781,250 shares of common stock. This figure includes the full exercise of the underwriters’ option to purchase an additional 1,406,250 shares. The shares were priced at $16.00 each, generating gross proceeds of …